The University of Sydney has commissioned Australia’s first 7-tesla MRI scanner, tripling the magnetic field strength of standard clinical MRI machines and enabling brain imaging at resolutions previously impossible outside of animal studies.

The machine, housed in a purpose-built facility at the Brain and Mind Centre, cost $18 million including the scanner itself, facility modifications, and specialized radiofrequency coils. It’s one of fewer than 100 ultra-high-field MRI scanners operating worldwide.

Professor Michael Breakspear, who directs the imaging facility, said the increased resolution opens new research possibilities. “We can now see anatomical structures and functional activity in the brain at sub-millimetre resolution. That’s the scale where you can start to resolve cortical layers and small nuclei that are completely invisible at standard field strengths.”

Most clinical MRI scanners operate at 1.5 or 3 tesla. The 7-tesla field strength provides a theoretical signal-to-noise ratio improvement of about 2.3 times compared to 3T, though practical benefits depend on the specific imaging sequence and what you’re trying to measure.

That extra signal can be traded for higher spatial resolution, faster imaging, or improved contrast between different tissue types. For brain imaging, researchers are particularly interested in resolving small structures deep in the brain that are affected early in neurodegenerative diseases.

The hippocampus, critical for memory formation, shows structural changes in early Alzheimer’s disease that are difficult to detect with standard MRI. At 7T, researchers can see hippocampal subfields and track how they atrophy over time, potentially enabling earlier diagnosis and better monitoring of disease progression.

Similar benefits apply to multiple sclerosis, Parkinson’s disease, and other neurological conditions where subtle brain changes precede clinical symptoms. Earlier detection could enable interventions that slow or prevent disease progression.

But ultra-high-field MRI isn’t ready for routine clinical use. Image quality at 7T is very sensitive to patient motion, scanner calibration, and radiofrequency field inhomogeneities. Getting good images requires extensive optimization and sometimes lengthy scan times that aren’t practical for clinical workflows.

Safety considerations also differ at 7T. The strong magnetic field creates forces on metallic objects that are three to five times larger than at 1.5T, raising concerns about medical implants. Patients with some types of pacemakers, aneurysm clips, or other metallic devices can’t be scanned.

Heating from radiofrequency pulses is also more of a concern at higher field strengths, requiring careful monitoring of specific absorption rate to avoid tissue heating.

The Sydney scanner is primarily a research tool enabling studies that wouldn’t be possible otherwise. Initial research programs focus on understanding brain connectivity in psychiatric disorders, tracking brain changes in aging, and developing biomarkers for early dementia detection.

One interesting application is functional MRI at high resolution. Standard fMRI detects brain activity based on blood oxygenation changes, but spatial resolution is limited by the size of blood vessels. At 7T, researchers can potentially resolve activity at the level of cortical columns, the fundamental computational units of the cerebral cortex.

That could provide new insights into how the brain processes sensory information, makes decisions, and generates conscious experience. These are fundamental neuroscience questions that have resisted investigation because appropriate tools didn’t exist.

The scanner will also be used to develop and validate new imaging techniques that might eventually be adapted for use at lower field strengths. Imaging methods are often initially developed on high-performance research scanners, then optimised for clinical scanners once the techniques mature.

Researchers from multiple Australian universities will have access to the scanner through a competitive application process. About 60% of scanner time is allocated to Sydney researchers, with the remaining 40% available to collaborators from other institutions.

International collaboration is important for ultra-high-field MRI research because the scanners are rare and expensive. Sydney researchers are participating in multi-site studies that pool data from 7T scanners worldwide, enabling larger sample sizes than any single site could achieve.

One challenge with multi-site imaging is ensuring consistency. Different scanners, even nominally identical models, produce subtly different images. Harmonization protocols that standardise image acquisition and processing are essential for combining data across sites.

The Sydney installation required significant facility modifications. The magnet weighs 40 tonnes and requires reinforced flooring, electromagnetic shielding to prevent interference with nearby electronics, and careful acoustic design because the scanner produces loud noise during operation.

Helium boil-off from the superconducting magnet also required special exhaust systems. The magnet operates at 4 Kelvin, maintained by a helium cooling system. Modern magnets are much more efficient than older designs, losing only about 1% of helium annually, but venting that helium safely is still important.

The facility includes a mock scanner where research participants can practice lying still while listening to recorded scanner noise. This helps reduce anxiety and improve real scan success rates, particularly important for studies involving children or patients with claustrophobia.

Operating costs for the scanner are estimated at $1.5-2 million annually, including staffing, maintenance, helium costs, and facility overhead. That’s substantially higher than clinical scanners, but comparable to other advanced research instruments like electron microscopes or mass spectrometers.

Funding for the scanner came from multiple sources including the Australian Research Council, the National Health and Medical Research Council, and philanthropic donations. This funding model is typical for research infrastructure that’s too expensive for individual research grants but too specialised to justify government core funding.

Whether 7T MRI eventually transitions to clinical use depends partly on cost reductions and partly on demonstrating clinical value. If ultra-high-field imaging enables earlier diagnosis or better treatment monitoring for major diseases, the clinical case strengthens.

Some manufacturers are now developing 7T scanners with more clinical-focused designs, suggesting the technology is moving toward clinical adoption, at least at major academic medical centers. Whether it ever becomes standard at community hospitals is less clear.

For now, the Sydney scanner represents a capability enhancement for Australian neuroscience research, enabling studies that would otherwise require international collaboration or wouldn’t be possible at all.